- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02769650
Stress-MRI Assessment After Right Coronary Artery CTO Recanalization
May 15, 2016 updated by: Meshalkin Research Institute of Pathology of Circulation
Clinical Significance of Stress-MRI Evaluation of Right Coronary Artery Chronic Total Occlusion Recanalization Efficacy in Patients With Coronary Artery Disease.
The hypothesis of this study is that Stress-MRI is a clinically significant method of myocardial perfusion assessment after coronary angioplasty with stenting of right coronary artery (RCA) chronic total occlusion (CTO) is performed.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
72
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Novosibirsk, Russian Federation, 630055
- State Research Institute of Circulation Pathology
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 75 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Stable angina, CCS FC II-IV
- "Right-dominance" coronary circulation according to coronary angiography
- Absence of other significant atherosclerotic coronary lesions (more than 65%)
- High risk of myocardium ischemia according to stress-MRI data (perfusion defect in 2 or more segments in the area of interest)
- Signed, documented informed consent prior to admission to the study
Exclusion Criteria:
- Acute coronary syndrome
- Contraindications for adenosine stress test
- Low and moderate risk of myocardium ischemia according to stress-MRI data (perfusion defect in less than 2 segments in the area of interest)
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Diagnostic
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Stress-MRI + Chronic total occlusion PCI
Pre- and postoperative stress-MRI with evaluation of myocardium perfusion defects + Coronary angioplasty with stenting of RCA CTO
|
A standard endovascular procedure is carried out under local anesthesia and under fluoroscopic control.
Recanalisation of coronary artery CTO is performed by the hydrophilic coronary wire, using the most appropriate technique.
Then balloon angioplasty of target lesion is provided.
After the angiographic control coronary stent is implanted.
After coronary wire removing control angiographic study is provided.
Medical therapy includes aspirin(acid acetylsalicylic) 125 - 300 mg/d and plavix(clopidogrel) in dose 300-600 mg prescription before the procedure and heparin (heparin sodium) injection during the procedure(5000 U iv).
After the procedure aspirin(acid acetylsalicylic) in dose 100 mg/d within long period should be prescribed in all the patients, and plavix(clopidogrel) in dose 75/d should be prescribed within 12 months.
A standard stress-MRI test with adenosine
|
|
Active Comparator: Stress-MRI + Optimal medicamentous treatment
Pre- and postoperative stress-MRI with evaluation of myocardium perfusion defects + Optimal medicamentous treatment
|
A standard stress-MRI test with adenosine
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Stress-MRI evaluation
Time Frame: Within 2 and 12 month after hospitalization
|
High risk of myocardium ischemia according to stress-MRI data (perfusion defect in 2 or more segments in the area of interest)
|
Within 2 and 12 month after hospitalization
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Clinical assessment
Time Frame: Within 2, 3, 4, 5, 6, 7, 8, 9, 10, 11 and 12 moths after hospitalization
|
Dynamical assessment of stable angina FC (CCS) and dyspnea FC (NYHA)
|
Within 2, 3, 4, 5, 6, 7, 8, 9, 10, 11 and 12 moths after hospitalization
|
|
Stress-MRI evaluation (2)
Time Frame: Within 2 and 12 month after hospitalization
|
Dynamics of perfusion in myocardium scar tissue according to stress-MRI data
|
Within 2 and 12 month after hospitalization
|
|
Major adverse cardiac and cerebrovascular events (MACCE)
Time Frame: During 1 year after first stress-MRI assessment
|
Major adverse cardiac and cerebrovascular events (MACCE) including: All-cause mortality, Myocardial infarction, Stroke, Stent thrombosis, Clinically indicated Target lesion revascularization, Any target lesion revascularization, Any target vessel revascularization.
|
During 1 year after first stress-MRI assessment
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
October 1, 2010
Primary Completion (Actual)
April 1, 2014
Study Completion (Actual)
April 1, 2014
Study Registration Dates
First Submitted
May 8, 2016
First Submitted That Met QC Criteria
May 8, 2016
First Posted (Estimate)
May 11, 2016
Study Record Updates
Last Update Posted (Estimate)
May 17, 2016
Last Update Submitted That Met QC Criteria
May 15, 2016
Last Verified
May 1, 2016
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- Stress-MRI 1.0
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Coronary Artery Disease
-
Infirmerie Protestante de LyonRecruitingCoronary Artery Bypass | Coronary Artery Disease(CAD) | Off Pump Coronary Artery Bypass Surgery | Hemodynamic Optimization | Hemodynamic Management | Off Pump Coronary Artery Bypass Graft | Coronary Artery Disease With Need for Bypass Surgery | NoradrenalineFrance
-
Shanghai Bluesail Boyuan Medical Technology Co....Not yet recruitingCoronary Artery Disease | Coronary Artery Calcification | Severe Coronary Artery DiseaseChina
-
I.R.C.C.S Ospedale Galeazzi-Sant'AmbrogioCompletedCoronary Artery Disease (CAD) | Atherosclerosis of Coronary ArteryItaly
-
Scitech Produtos Medicos SANot yet recruitingCoronary Artery Disease (CAD) | Multivessel Coronary Artery Disease | Complex Coronary Lesions | Calcific Coronary Arteriosclerosis | Small Vessel Ischemic Disease | Stenosis CoronaryBrazil
-
Istanbul Mehmet Akif Ersoy Educational and Training...Bakirkoy Dr. Sadi Konuk Research and Training Hospital; Ege University; Istanbul... and other collaboratorsActive, not recruitingCoronary Artery Disease (CAD) | Coronary Bifurcation Lesion | Left Main Coronary Artery StenosisTurkey (Türkiye)
-
University Medical Centre LjubljanaRecruitingCoronary Artery Disease With Myocardial InfarctionSlovenia
-
EBI Anti Sepsis BVCR2O B.V.Not yet recruitingCoronary Artery Disease (CAD) | Coronary Artery Bypass Graft Surgery(CABG)United States, Netherlands, Belgium, United Kingdom
-
Fundación EPICActive, not recruitingCoronary Artery Disease | Left Main Coronary Artery Disease | Left Main Coronary Artery Stenosis | Restenosis, CoronarySpain
-
Mahidol UniversityThe Princess Mantarop Kamalas Foundation, The Nurses' Association of Thailand and other collaboratorsActive, not recruitingCoronary Artery Disease (CAD) | Postoperative Recovery | Coronary Artery Bypass Graft (CABG)Thailand
-
Elixir Medical CorporationIstituto Clinico HumanitasActive, not recruitingCoronary Artery Disease | Chronic Total Occlusion of Coronary Artery | Multi Vessel Coronary Artery Disease | Bifurcation of Coronary Artery | Long Lesions Coronary Artery DiseaseItaly
Clinical Trials on CTO coronary angioplasty
-
BridgePoint MedicalCompletedChronic Total OcclusionUnited States
-
University Hospital, MontpellierCompleted
-
University of California, DavisKaiser Permanente; Clovis Community Hospital; Doctors Medical Center; Los Alamitos... and other collaboratorsCompletedCoronary Artery DiseaseUnited States
-
National Taiwan University HospitalChang Gung Memorial Hospital; Taipei Veterans General Hospital, TaiwanRecruitingChronic Total Occlusion (CTO)Taiwan
-
Groupe Hospitalier de la Rochelle Ré AunisBBraun Medical SASActive, not recruiting
-
University College, LondonNational Institute for Cardiovascular Outcomes Research; British Cardiovascular... and other collaboratorsCompletedPercutaneous Coronary InterventionUnited Kingdom
-
Lauri MansikkaniemiCompletedChronic Total Occlusion of Coronary Artery | Coronary Artery Disease (CAD) | Chronic Total Occlusion (CTO)Finland
-
Imperial College LondonVolcano CorporationCompletedStable AnginaUnited Kingdom
-
Imperial College LondonBasildon and Thurrock Hospitals NHS FoundationTrustCompletedStable AnginaUnited Kingdom
-
Royal Sussex County HospitalCompletedStenosis | Angina | Ischaemic Heart DiseasesUnited Kingdom